BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 23658414)

  • 1. Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures.
    Singh VK; Beattie LA; Seed TM
    J Radiat Res; 2013 Nov; 54(6):973-88. PubMed ID: 23658414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cytokines by radioprotective tocopherol analogs.
    Singh VK; Shafran RL; Jackson WE; Seed TM; Kumar KS
    Exp Mol Pathol; 2006 Aug; 81(1):55-61. PubMed ID: 16426603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
    Singh VK; Hauer-Jensen M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans).
    Nukala U; Thakkar S; Krager KJ; Breen PJ; Compadre CM; Aykin-Burns N
    Antioxidants (Basel); 2018 Feb; 7(2):. PubMed ID: 29473853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E Analogs as Radiation Response Modifiers.
    Singh PK; Krishnan S
    Evid Based Complement Alternat Med; 2015; 2015():741301. PubMed ID: 26366184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.
    Singh VK; Seed TM
    Int J Radiat Biol; 2017 Sep; 93(9):851-869. PubMed ID: 28650707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioprotective efficacy of delta-tocotrienol, a vitamin E isoform, is mediated through granulocyte colony-stimulating factor.
    Singh VK; Wise SY; Scott JR; Romaine PL; Newman VL; Fatanmi OO
    Life Sci; 2014 Mar; 98(2):113-22. PubMed ID: 24486300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics guided design of tocoflexol: a new radioprotectant tocotrienol with enhanced bioavailability.
    Compadre CM; Singh A; Thakkar S; Zheng G; Breen PJ; Ghosh S; Kiaei M; Boerma M; Varughese KI; Hauer-Jensen M
    Drug Dev Res; 2014 Feb; 75(1):10-22. PubMed ID: 24648045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Pharmacological Countermeasures to Attenuate the Acute Radiation Syndrome-A Concise Review.
    Hofer M; Hoferová Z; Depeš D; Falk M
    Molecules; 2017 May; 22(5):. PubMed ID: 28534834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation.
    Pannkuk EL; Laiakis EC; Fornace AJ; Fatanmi OO; Singh VK
    Health Phys; 2018 Jul; 115(1):3-11. PubMed ID: 29787425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.
    Singh VK; Romaine PL; Newman VL; Seed TM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1399-1408. PubMed ID: 27610458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status.
    Singh VK; Garcia M; Seed TM
    Int J Radiat Biol; 2017 Sep; 93(9):870-884. PubMed ID: 28657406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
    Singh VK; Kulkarni S; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Hendrickson H; Gulani J; Ghosh SP; Kumar KS; Hauer-Jensen M
    Radiat Res; 2016 Mar; 185(3):285-98. PubMed ID: 26930378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appraisal of mechanisms of radioprotection and therapeutic approaches of radiation countermeasures.
    Mishra KN; Moftah BA; Alsbeih GA
    Biomed Pharmacother; 2018 Oct; 106():610-617. PubMed ID: 29990850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate.
    Garg S; Garg TK; Wise SY; Fatanmi OO; Miousse IR; Savenka AV; Basnakian AG; Singh VK; Hauer-Jensen M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocopherols and tocotrienols in membranes: a critical review.
    Atkinson J; Epand RF; Epand RM
    Free Radic Biol Med; 2008 Mar; 44(5):739-64. PubMed ID: 18160049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol.
    Cheema AK; Mehta KY; Fatanmi OO; Wise SY; Hinzman CP; Wolff J; Singh VK
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.
    Aggarwal BB; Sundaram C; Prasad S; Kannappan R
    Biochem Pharmacol; 2010 Dec; 80(11):1613-31. PubMed ID: 20696139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects.
    Shrum SA; Nukala U; Shrimali S; Pineda EN; Krager KJ; Thakkar S; Jones DE; Pathak R; Breen PJ; Aykin-Burns N; Compadre CM
    Antioxidants (Basel); 2023 Nov; 12(11):. PubMed ID: 38001840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives.
    Singh VK; Seed TM
    Expert Opin Investig Drugs; 2023 Jan; 32(1):25-35. PubMed ID: 36655861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.